India's Biological E. to produce Johnson & Johnson's COVID-19 vaccine

Biological E., based in the southern Indian city of Hyderabad, also plans to produce 75 million to 80 million doses of its own vaccine a month from August. The drug has been developed with Baylor College of Medicine in Houston and Dynavax Technologies Corp.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news